Answer
Epcoritamab’s population pharmacokinetic model-derived geometric mean half-life at the full 48 mg dose ranges from 22 to 25 days depending on dosing frequency, and its half-life is concentration dependent.
Sources for this answer
- Tepkinly 4 mg/0.8 ml solution for injectionAbbVie Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 12Document updated
Sources checked